Early indices of methyl mercury toxicity and their use in treatment evaluation.
Mercury distribution, food consumption, body weight, and in vivo protein synthesis were compared as criteria for evaluating the efficacy of D-penicillamine (DPA) in treating experimental methyl mercury (MM) intoxication. Female rats were orally administered MM hydroxide at 40 mg/kg and, after a 7- to 8-d latency period, displayed characteristic neurological signs of MM intoxication. Within 24 h of MM exposure food consumption decreased 75% causing a 12-g drop in body weight, and synthesis of whole blood and kidney protein increased. Protein synthesis in liver was increased 39% by MM after 3 d, and that in cerebellum was decreased 15% after 7 d. Treatment with DPA (1.2 g/kg.d sc on d 2, 3, and 4) prevented the appearance of neurological signs. DPA lowered the Hg content of all tissues; restored food consumption of control levels; increased the onset and amount of body weight gain; returned synthesis of blood, liver, and kidney proteins to control levels; and prevented the decrease in protein synthesis in cerebellum. By itself, DPA produced a transitory decrease in both food consumption and body weight, which could be prevented with vitamin B6. Vitamin B6 antagonized DPA's reversal of MM's action on protein synthesis. Furthermore, DPA and/or vitamin B6 had a variety of effects on protein synthesis in control rats. Thus it was not possible to use protein synthesis to predict the efficacy of the combination of DPA and vitamin B6 as found for the parameters of food consumption, body weight, and Hg distribution. Since changes in body weight and food consumption were the earliest and most pronounced and consistent responses to MM and effective DPA treatment, they were considered the best criteria for evaluating treatment efficacy in experimental MM poisoning in rats.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D005260:Female; D008630:Mercury Poisoning / Q000188:drug therapy* / Q000378:metabolism; D008767:Methylmercury Compounds / Q000378:metabolism / Q000506:poisoning*; D010396:Penicillamine / Q000627:therapeutic use*; D014176:Protein Biosynthesis; D011736:Pyridoxine / Q000627:therapeutic use; D051381:Rats; D014018:Tissue Distribution
D008767:Methylmercury Compounds; D010396:Penicillamine; D011736:Pyridoxine